Recent in People News (page 9 of 15)
Oct 8, 2014
Ni'Kita Wilson is joining Aware Products as VP of sales and innovation. Wilson is also coming back to the Cosmetics & Toiletries team as a regular columnist, having previously written the Read the Label column.
Sep 23, 2014
Cosmetics & Toiletries is pleased to welcome Jennifer Marsh, PhD, of Procter & Gamble, to its highly esteemed Scientific Advisory Board. As an accomplished Principal Scientist in the Beauty and Technology division, Marsh has conducted multiple studies on bleach and oxidative chemistry for hair color technologies.
Sep 3, 2014
Koh Akiyama has been appointed president and CEO of Presperse, replacing Sumio Hino, who has been appointed to lead the management of Sumitomo Corp.’s global cosmetics business.
Aug 25, 2014
Robert Margolskee, MD, PhD, succeeds Gary Beauchamp, PhD, who is stepping down after 24 years with the organization.
Aug 5, 2014
At the Society of Cosmetic Scientists' (SCS) 2014 Annual General Meeting in London, the 2014/2015 officers and council were elected.
Jul 16, 2014
Croda Inc. has appointed two employees to roles in its North American consumer care sales team.
Jun 12, 2014
J. Leon Lichtin, PhD, founder of the University of Cincinnati cosmetic science program, passed away on June 10, 2014, at the age of 90.
Jun 4, 2014
Canadian-based Azelis announced the appointment of Frans J. des Tombe as managing director, effective June 2, 2014. He replaces Tony Craske, who will now be based in Europe and serve as international business director of Azelis Personal Care.
Jun 4, 2014
Lonza Group Ltd. announced the appointment of Sven Abend to its Executive Committee (EC), effective July 1, 2014.
May 28, 2014
Elevance Renewable Sciences Inc. has named Steven Mills, former Chief Financial Officer at Amyris, Inc., to its board of directors.
May 13, 2014
AAK announced it has appointed new team members in anticipation of growth due to the demand for natural and sustainable products as well as rising consumption in China, India and Brazil.
May 5, 2014
Lonza Group Ltd. has announced changes to its executive committee, reportedly to ensure the continuity and focused delivery of its pharmaceuticals and biotechnology division growth strategy.